Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Sebastian E.E. Schagen"'
Autor:
Eva M.M. Hoytema van Konijnenburg, Ilse K. Luirink, Sebastian E.E. Schagen, Marc Engelen, Kevin Berendse, Bwee Tien Poll-The, Malika Chegary
Publikováno v:
Molecular Genetics and Metabolism Reports, Vol 23, Iss , Pp - (2020)
Externí odkaz:
https://doaj.org/article/52fbed6771b643089ad345807f92c836
Publikováno v:
The Journal of Clinical Endocrinology and Metabolism
Journal of Clinical Endocrinology and Metabolism, 105(12). The Endocrine Society
Journal of Clinical Endocrinology and Metabolism, 105(12). Endocrine Society
The Journal of clinical endocrinology and metabolism, 105(12). The Endocrine Society
Schagen, S E E, Wouters, F M, Cohen-Kettenis, P T, Gooren, L J & Hannema, S E 2020, ' Bone Development in Transgender Adolescents Treated With GnRH Analogues and Subsequent Gender-Affirming Hormones ', The Journal of clinical endocrinology and metabolism, vol. 105, no. 12 . https://doi.org/10.1210/clinem/dgaa604
Journal of Clinical Endocrinology and Metabolism, 105(12). The Endocrine Society
Journal of Clinical Endocrinology and Metabolism, 105(12). Endocrine Society
The Journal of clinical endocrinology and metabolism, 105(12). The Endocrine Society
Schagen, S E E, Wouters, F M, Cohen-Kettenis, P T, Gooren, L J & Hannema, S E 2020, ' Bone Development in Transgender Adolescents Treated With GnRH Analogues and Subsequent Gender-Affirming Hormones ', The Journal of clinical endocrinology and metabolism, vol. 105, no. 12 . https://doi.org/10.1210/clinem/dgaa604
Context Hormonal interventions in adolescents with gender dysphoria may have adverse effects, such as reduced bone mineral accrual. Objective To describe bone mass development in adolescents with gender dysphoria treated with gonadotropin-releasing h
Autor:
Ilse K. Luirink, Eva M. M. Hoytema van Konijnenburg, Sebastian E.E. Schagen, Bwee Tien Poll-The, Malika Chegary, Kevin Berendse, Marc Engelen
Publikováno v:
Molecular Genetics and Metabolism Reports
Molecular Genetics and Metabolism Reports, Vol 23, Iss, Pp-(2020)
Molecular genetics and metabolism reports, 23:100590. Elsevier BV
Molecular Genetics and Metabolism Reports, Vol 23, Iss, Pp-(2020)
Molecular genetics and metabolism reports, 23:100590. Elsevier BV
Autor:
Sebastian E.E. Schagen, Tessa Brik, Martine C. de Vries, Hannema Se, A. Meissner, Lieke J.J.J. Vrouenraets
Publikováno v:
Brik, T, Vrouenraets, L J J J, Schagen, S E E, Meissner, A, de Vries, M C & Hannema, S E 2019, ' Use of Fertility Preservation Among a Cohort of Transgirls in the Netherlands ', Journal of Adolescent Health, vol. 64, no. 5, pp. 589-593 . https://doi.org/10.1016/j.jadohealth.2018.11.008
Journal of adolescent health, 64(5), 589-593. Elsevier USA
Journal of Adolescent Health, 64(5), 589-593. Elsevier USA
Journal of adolescent health, 64(5), 589-593. Elsevier USA
Journal of Adolescent Health, 64(5), 589-593. Elsevier USA
Purpose The primary aims of the study are to examine the rate of attempted fertility preservation (FP) among a Dutch cohort of transgirls who started gonadotropin-releasing hormone analog treatment and the reasons why adolescents did or did not choos
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1496ca18cc5d72017897f6f5d58807d3
https://research.vumc.nl/en/publications/692b47d1-6805-4a4e-9980-2baacf0b11d3
https://research.vumc.nl/en/publications/692b47d1-6805-4a4e-9980-2baacf0b11d3
Autor:
Hannema Se, Paul Lustenhouwer, Sebastian E.E. Schagen, Peggy T. Cohen-Kettenis, Henriette A. Delemarre-van de Waal
Publikováno v:
Journal of Sexual Medicine, 15(9), 1357-1363. Wiley-Blackwell
Schagen, S E E, Lustenhouwer, P, Cohen-Kettenis, P T, Delemarre-van de Waal, H A & Hannema, S E 2018, ' Changes in Adrenal Androgens During Puberty Suppression and Gender-Affirming Hormone Treatment in Adolescents With Gender Dysphoria ', Journal of Sexual Medicine, vol. 15, no. 9, pp. 1357-1363 . https://doi.org/10.1016/j.jsxm.2018.07.017, https://doi.org/10.1016/j.jsxm.2018.07.017
The Journal of Sexual Medicine, 15(9), 1357-1363
Schagen, S E E, Lustenhouwer, P, Cohen-Kettenis, P T, Delemarre-van de Waal, H A & Hannema, S E 2018, ' Changes in Adrenal Androgens During Puberty Suppression and Gender-Affirming Hormone Treatment in Adolescents With Gender Dysphoria ', Journal of Sexual Medicine, vol. 15, no. 9, pp. 1357-1363 . https://doi.org/10.1016/j.jsxm.2018.07.017, https://doi.org/10.1016/j.jsxm.2018.07.017
The Journal of Sexual Medicine, 15(9), 1357-1363
Introduction Gender-affirming hormone treatment is known to affect adrenal androgen levels in adult individuals with gender dysphoria (GD). This may be clinically relevant because the adrenal gland plays a critical role in many different metabolic pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d92fd745353de8c87874c1371d210219
https://hdl.handle.net/1887/96314
https://hdl.handle.net/1887/96314
Autor:
Henriette A. Delemarre-van de Waal, Sebastian E.E. Schagen, Julie Bakker, Elseline Hoekzema, Baudewijntje P.C. Kreukels, Peggy T. Cohen-Kettenis, Dick J. Veltman
Publikováno v:
Hoekzema, E, Schagen, S E E, Kreukels, B P C, Veltman, D J, Cohen-Kettenis, P T, Delemarre-van d Waal, H A & Bakkera, J 2015, ' Regional volumes and spatial volumetric distribution of gray matter in the gender dysphoric brain ', Psychoneuroendocrinology, vol. 55, pp. 59-71 . https://doi.org/10.1016/j.psyneuen.2015.01.016
Psychoneuroendocrinology, 55, 59-71. Elsevier Limited
Psychoneuroendocrinology, 55, 59-71. Elsevier B.V.
Psychoneuroendocrinology, 55, 59-71. Elsevier Limited
Psychoneuroendocrinology, 55, 59-71. Elsevier B.V.
The sexual differentiation of the brain is primarily driven by gonadal hormones during fetal development. Leading theories on the etiology of gender dysphoria (GD) involve deviations herein. To examine whether there are signs of a sex-atypical brain
Autor:
Peggy T. Cohen-Kettenis, Sebastian E.E. Schagen, Henriette A. Delemarre-van de Waal, Sabine E. Hannema
Publikováno v:
Hannema, S E, Schagen, S E E, Cohen-Kettenis, P T & Delemarre-Van De Waal, H A 2017, ' Efficacy and safety of pubertal induction using 17β-estradiol in transgirls ', Journal of Clinical Endocrinology and Metabolism, vol. 102, no. 7, pp. 2356-2363 . https://doi.org/10.1210/jc.2017-00373
The Journal of clinical endocrinology and metabolism, 102(7), 2356-2363. The Endocrine Society
Journal of Clinical Endocrinology and Metabolism, 102(7), 2356-2363
Journal of Clinical Endocrinology and Metabolism, 102(7), 2356-2363. The Endocrine Society
The Journal of clinical endocrinology and metabolism, 102(7), 2356-2363. The Endocrine Society
Journal of Clinical Endocrinology and Metabolism, 102(7), 2356-2363
Journal of Clinical Endocrinology and Metabolism, 102(7), 2356-2363. The Endocrine Society
Context: Puberty suppression using gonadotropin-releasing hormone agonists, followed by induc tion of the desired sex characteristics using sex steroids, has been recommended by the current guidelines as the treatment of choice for gender dysphoric a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5dc65da2dfae334839f3414cca90e89d
https://research.vumc.nl/en/publications/30a6aa00-0f5a-4b93-bc15-03f8a542fa2e
https://research.vumc.nl/en/publications/30a6aa00-0f5a-4b93-bc15-03f8a542fa2e
Autor:
Peggy T. Cohen-Kettenis, Sebastian E.E. Schagen, Sabine E. Hannema, Henriette A. Delemarre-van de Waal
Publikováno v:
The Journal of Sexual Medicine, 13(7), 1125-1132
Journal of Sexual Medicine, 13(7):130, 1125-1132. Wiley-Blackwell
Schagen, S E E, Cohen-Kettenis, P T, Delemarre-van de Waal, H A & Hannema, S E 2016, ' Efficacy and Safety of Gonadotropin-Releasing Hormone Agonist Treatment to Suppress Puberty in Gender Dysphoric Adolescents ', Journal of Sexual Medicine, vol. 13, no. 7, 130, pp. 1125-1132 . https://doi.org/10.1016/j.jsxm.2016.05.004
Journal of Sexual Medicine, 13(7):130, 1125-1132. Wiley-Blackwell
Schagen, S E E, Cohen-Kettenis, P T, Delemarre-van de Waal, H A & Hannema, S E 2016, ' Efficacy and Safety of Gonadotropin-Releasing Hormone Agonist Treatment to Suppress Puberty in Gender Dysphoric Adolescents ', Journal of Sexual Medicine, vol. 13, no. 7, 130, pp. 1125-1132 . https://doi.org/10.1016/j.jsxm.2016.05.004
Introduction Puberty suppression using gonadotropin-releasing hormone agonists (GnRHas) is recommended by current guidelines as the treatment of choice for gender dysphoric adolescents. Although GnRHas have long been used to treat precocious puberty,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::177915d65a3a868f322e6aa0ac05f8be
http://hdl.handle.net/1887/113968
http://hdl.handle.net/1887/113968
Autor:
Henriette A. Delemarre-van de Waal, Sebastian E.E. Schagen, Peggy T. Cohen-Kettenis, Annemieke S. Staphorsius, Sarah M. Burke, Julie Bakker, Dick J. Veltman, Baudewijntje P.C. Kreukels, Femke M. Wouters
Publikováno v:
Psychoneuroendocrinology, 56, 190-199. Elsevier Limited
Psychoneuroendocrinology, 56, 190-9. Elsevier B.V.
Staphorsius, A S, Kreukels, B P C, Cohen-Kettenis, P T, Veltman, D J, Burke, S M, Schagen, S E E, Wouters, F M, Delemarre-van de Waal, H A & Bakker, J 2015, ' Puberty suppression and executive functioning: An fMRI-study in adolescents with gender dysphoria ', Psychoneuroendocrinology, vol. 56, pp. 190-199 . https://doi.org/10.1016/j.psyneuen.2015.03.007
Psychoneuroendocrinology, 56, 190-9. Elsevier B.V.
Staphorsius, A S, Kreukels, B P C, Cohen-Kettenis, P T, Veltman, D J, Burke, S M, Schagen, S E E, Wouters, F M, Delemarre-van de Waal, H A & Bakker, J 2015, ' Puberty suppression and executive functioning: An fMRI-study in adolescents with gender dysphoria ', Psychoneuroendocrinology, vol. 56, pp. 190-199 . https://doi.org/10.1016/j.psyneuen.2015.03.007
Adolescents with gender dysphoria (GD) may be treated with gonadotropin releasing hormone analogs (GnRHa) to suppress puberty and, thus, the development of (unwanted) secondary sex characteristics. Since adolescence marks an important period for the
Autor:
Peggy T. Cohen-Kettenis, Henriette A. Delemarre-van de Waal, Remi S. Soleman, Cornelis B. Lambalk, Femke Wouters, Dick J. Veltman, Sebastian E.E. Schagen, Baudewijntje P.C. Kreukels
Publikováno v:
The Journal of Sexual Medicine, 10(8), 1969-1977
Journal of Sexual Medicine, 10(8), 1969-1977. Wiley-Blackwell
Soleman, R S, Schagen, S E E, Veltman, D J, Kreukels, B P C, Cohen-Kettenis, P T, Lambalk, C B, Wouters, F M & Delemarre-van de Waal, H A 2013, ' Sex Differences in Verbal Fluency during Adolescence: A Functional Magnetic Resonance Imaging Study in Gender Dysphoric and Control Boys and Girls ', Journal of Sexual Medicine, vol. 10, no. 8, pp. 1969-1977 . https://doi.org/10.1111/jsm.12083
journal of sexual medicine, 10(8), 1969-1977. Wiley-Blackwell
Journal of Sexual Medicine, 10(8), 1969-1977. Wiley-Blackwell
Soleman, R S, Schagen, S E E, Veltman, D J, Kreukels, B P C, Cohen-Kettenis, P T, Lambalk, C B, Wouters, F M & Delemarre-van de Waal, H A 2013, ' Sex Differences in Verbal Fluency during Adolescence: A Functional Magnetic Resonance Imaging Study in Gender Dysphoric and Control Boys and Girls ', Journal of Sexual Medicine, vol. 10, no. 8, pp. 1969-1977 . https://doi.org/10.1111/jsm.12083
journal of sexual medicine, 10(8), 1969-1977. Wiley-Blackwell
Introduction. In the literature, verbal fluency (VF) is generally described as a female-favoring task. Although it is conceivable that this sex difference only evolves during adolescence or adulthood under influence of sex steroids, this has never be
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f3578dce2e4c46c93ee431cbb8441221
https://doi.org/10.1111/jsm.12083
https://doi.org/10.1111/jsm.12083